Robert Torray - Torray Fund Investment Strategy & Portfolio Analysis
How Torray Fund allocates capital, manages risk, and constructs its portfolio — based on SEC 13F filings.
As of Jun 30, 2026, Robert Torray's Torray Fund portfolio reflects a quant / systematic investor approach across 88 reported 13F positions. Portfolio returns are distributed across holdings, with the top five positions representing approximately 22% of total exposure. Across 88 reported holdings, economic exposure is broadly distributed across technology, healthcare, and financials without dominant single-name concentration. Exposure to high-growth and technology-oriented segments is elevated relative to peers, with performance weighted across healthcare, financials, and utilities. The portfolio exhibits extremely low turnover, reinforcing a patient, conviction-led investment approach. Distinctive traits include Long-Term Holder, Broadly Diversified, Economically Diversified.
Investment Style
Value, growth, quality, and behavioral classification from latest 13F holdings.
Primary type: Quant / Systematic Investor
Traits: Long-Term Holder, Broadly Diversified, Economically Diversified, Structurally Diversified
Turnover profile
Moderate
Holding horizon
Long-Term
Portfolio Construction
Concentration and position sizing in the latest filing.
Portfolio construction is lowly concentrated: top three names represent 14.7% of assets, top five 21.8%, and the largest single position is 5.7%.
Top 3 weight
14.7%
Top 5 weight
21.8%
Top 10 weight
37.6%
Largest position
5.7%
Top holdings: Broadcom Inc., Royalty Pharma, Constellation Energy Corporatio, CNA Financial Corporation, Chevron Corporation — view full holdings
Sector Preferences
Where capital is allocated by sector.
Capital is tilted toward Technology and Healthcare, with 12 sectors represented in the latest filing.
Leading sectors: Technology, Healthcare, Financial Services
Risk Framework
Concentration, diversification, and turnover tolerance.
This investor accepts low single-name risk (largest position 5.7%, top ten 37.6%) and high economic diversification (HHI 0.02). Turnover tolerance maps to a moderate profile.
Largest position
5.7%
Top 10 weight
37.6%
Max sector
24.3%
Diversification
High
Strategy Evolution
How the strategy changed between the two most recent filing periods.
Mar 31, 2026 → Jun 30, 2026
- Position count increased from 86 to 88 (+2 names).
- Top-five concentration fell from 22.6% to 21.8%.
- Dominant sector mix shifted from Technology, Financial Services to Technology, Healthcare.
- Largest holding changed from Royalty Pharma to Broadcom Inc..
- Quarter-over-quarter portfolio weight turnover: 11.1%.
For trade-level changes, see the Activity page. View activity.
Similar Investors
Peer group with comparable portfolio behavior.
Similar-investor comparisons are coming soon.